Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | SHBG | P04278 | 1/20 | 0.54 |
| ▸ | UQCRB | P14927 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | SNCA | P37840 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6324479 | 0.82 | CYP3A4 (0.63) | CYP3A4TSHRUQCRBALDH1A1CYP1A2 | |
| SCHEMBL8962181 | 0.82 | SHBG (0.52) | CYP3A4TSHRSHBGALDH1A1CYP1A2 | |
| SCHEMBL411772 | 0.82 | SHBG (0.59) | CYP3A4TSHRSHBGALDH1A1MEN1 | |
| Resorcinol SCHEMBL8462567 | 0.80 | SHBG (0.78) | CYP3A4TSHRSHBGUQCRBALDH1A1 | |
| SCHEMBL19985680 | 0.79 | SHBG (0.50) | CYP3A4SHBGALDH1A1MEN1MAPT | |
| SCHEMBL1920769 | 0.78 | CYP3A4 (0.86) | CYP3A4TSHRALDH1A1CYP1A2MEN1 | |
| SCHEMBL8962143 | 0.77 | ALDH1A1 (0.56) | CYP3A4SHBGALDH1A1CYP1A2MEN1 | |
| SCHEMBL20951293 | 0.77 | SHBG (0.53) | CYP3A4TSHRSHBGUQCRBALDH1A1 | |
| SCHEMBL3855587 | 0.77 | SHBG (0.59) | CYP3A4SHBGUQCRBALDH1A1MEN1 | |
| SCHEMBL465314 | 0.74 | SHBG (0.47) | CYP3A4TSHRSHBGALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3516019-B1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS CORP (US) | 2023-06-14 | — | — | EP | disclosed |
| EP-3516020-B1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS CORP (US) | 2022-05-25 | — | — | EP | disclosed |
| US-10723969-B2 | Lubricant compositions stabilized by mixtures of diarylamine and hydroxydiarylamine antioxidants | LANXESS SOLUTIONS US INC. (US) | 2020-07-28 | — | — | US | disclosed |
| US-10563145-B2 | Alkylated 3-hydroxydiphenylamine antioxidants | LANXESS SOLUTIONS US INC. (US) | 2020-02-18 | — | — | US | disclosed |
| WO-2018057364-A1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. (US) | 2018-03-29 | — | — | WO | disclosed |
| WO-2018057366-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. (US) | 2018-03-29 | — | — | WO | disclosed |
| US-20180079985-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
| US-20180079985-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
| US-20180079987-A1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
| US-20180079987-A1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079985-A1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | GPX4, GSTO1, LPO | CYP3A4 478/4885TSHR 4723/4885SHBG 376/4885 |
| US-10563145-B2 | Alkylated 3-hydroxydiphenylamine antioxidants | GPX4, GSTO1, LPO | CYP3A4 478/4885TSHR 4723/4885SHBG 376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.